This article addresses the critical challenge of medication-induced circadian disruption in biomedical research and drug development.
Accurate assessment of circadian hormones like cortisol and melatonin is pivotal for research in chronobiology, drug development, and clinical diagnostics.
Accurately identifying and sampling individuals with low melatonin production is critical for research on circadian rhythms, sleep disorders, and the development of chronotherapeutics.
This article provides a comprehensive framework for designing and implementing circadian hormone protocols in shift work research.
Accurate measurement of circadian hormones like melatonin and cortisol is pivotal for understanding their role in health, disease, and chronotherapy.
Accurately determining the Dim Light Melatonin Onset (DLMO) is crucial for circadian rhythm research and the development of chronotherapies.
This article provides researchers and drug development professionals with a complete framework for implementing constant routine protocols in circadian hormone studies.
The circadian rhythm of glucocorticoids (GCs), primarily cortisol, is a critical biomarker for assessing hypothalamic-pituitary-adrenal (HPA) axis function, with significant implications for neuroendocrine research, metabolic studies, and the development of...
This article provides a comprehensive overview of Cortisol Awakening Response (CAR) measurement for researchers and drug development professionals.
This article provides a comprehensive resource for researchers and drug development professionals on the Dim Light Melatonin Onset (DLMO) protocol, the gold standard for assessing human circadian phase.